BioSpace News Archive

The global ECG Management Systems Market is likely to be driven by the rising frequency of cardiac arrhythmia and rising demand for ambulatory monitoring equipment.

The medical condition when one cannot voluntary control one’s ability to urinate or defecate, then it is known as incontinence.

SciBase Holding AB, a leading developer of augmented intelligence-based solutions for skin disorders, announced that a new study supporting the use of Nevisense in diagnosing melanoma has been published in “SKIN - The journal of cutaneous medicine”.

MRM Health announced that it will present scientific data from its portfolio at the 6th Microbiome Movement Drug Development Europe Summit, resulting from its proprietary and unique CORAL™ platform technology.

Kyverna Therapeutics, a cell therapy company engineering a new class of therapies for serious autoimmune diseases, announced it has closed an oversubscribed $85 million Series B financing round led by Northpond Ventures.

MediciNova, Inc. and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a Notice of Intention to Grant from the European Patent Office for a pending patent application which covers MN-001 (tipelukast) and MN-002 (a major metabolite of MN-001) for hepatic ballooning.

Avivagen Inc announces a CEO update to shareholders.

Scipio bioscience Launches Commercialization in Europe of Asteria©, its RNA Sequencing Kit.

BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the outcome of a peer-reviewed study published in the journal of Obstetrics & Gynecology that showed molecular diagnostics could improve the accuracy of vaginitis diagnosis and lead to more appropriate and timely treatment decisions.

TYME Technologies, Inc. today announced the discontinuation of SM-88 with MPS in the Precision Promise trial in metastatic pancreatic cancer.